pharmaceutical investing Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma
pharmaceutical investing Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
